The combination of decreased TNFα, IL-1β, and COX-2 found in the PDTC treated epidermis provides compelling evidence that Hr is capable of modulating epithelial inflammation via regulation of the NFκB pathway and thereby further contributes to tumor promotion. The gene discussed is IL1B; the disease is neoplasm.